Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cellceutix adds new indication to IND application for Kevetrin

Oct. 11, 2011

Adherex to discuss development of sodium thiosulfate with FDA advisory committee

Oct. 10, 2011

BAY-1017858 shows promise in vitro and in vivo

Oct. 10, 2011

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Oct. 10, 2011

Millennium withdraws sNDA for Velcade

Oct. 7, 2011

BioCancell recruits first patients in BC-819 pancreatic cancer study

Oct. 7, 2011

Enrollment complete in Peregrine phase II NSCLC trial

Oct. 7, 2011

Pfizer licenses neratinib to Puma Biotechnology

Oct. 7, 2011

New PLK1 inhibitors developed

Oct. 7, 2011

Bavarian Nordic gains rights to NCI anticancer vaccine candidate

Oct. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...